Insider · CIK 0001272181

SCHAFER CAROL

Reports to the SEC for 6 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001272181

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	IMNMImmunome Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+9,897 sh	—	—	9,897
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-05-13	INSMINSMED IncA Award	Director	AAward	+3,305 sh	—	—	66,622
2026-01-28	RPTXRepare Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2026-01-28	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37.9K sh	—	—	0
2025-06-10	IMNMImmunome Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,864
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500
2025-05-15	INSMINSMED IncA Award	Director	AAward	+5,058 sh	—	—	63,317
2024-06-17	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.2K sh	—	—	27,200
2024-06-13	IMNMImmunome Inc. · Stock option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,333
2024-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2024-05-13	INSMINSMED IncA Award	Director	AAward	+13.2K sh	—	—	58,259
2024-01-02	IMNMImmunome Inc. · Stock option (right to buy)A Award	Director	AAward	+32.9K sh	—	—	32,934
2023-06-08	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.2K sh	—	—	27,200
2023-05-31	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2023-05-11	INSMINSMED IncA Award	Director	AAward	+13.2K sh	—	—	45,097
2022-06-23	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-06-21	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2022-05-13	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+49K sh	—	—	49,000
2022-05-11	INSMINSMED IncA Award	Director	AAward	+14.6K sh	—	—	31,905
2021-06-22	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2021-06-08	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2021-06-03	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+46K sh	—	—	46,000
2021-05-13	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2021-05-12	INSMINSMED IncA Award	Director	AAward	+7,558 sh	—	—	17,260
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2021-04-01	Aceragen, Inc.A Award	Director	AAward	+11.2K sh	$1.32	+$14.8K	59,665
2021-01-04	Aceragen, Inc.A Award	Director	AAward	+3,620 sh	$4.02	+$14.6K	48,488
2020-10-01	Aceragen, Inc.A Award	Director	AAward	+6,111 sh	$2.25	+$13.7K	44,868
2020-07-01	Aceragen, Inc.A Award	Director	AAward	+7,681 sh	$1.79	+$13.7K	38,757
2020-06-23	RPTXRepare Therapeutics Inc.P Purchase	Director	PPurchase	+8,000 sh	$20.00	+$160K	8,000
2020-05-14	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-12	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11.5K sh	—	—	11,500
2020-05-12	INSMINSMED IncA Award	Director	AAward	+8,097 sh	—	—	9,702
2020-04-01	INSMINSMED IncA Award	Director	AAward	+1,605 sh	—	—	1,605
2020-04-01	Aceragen, Inc.A Award	Director	AAward	+10.6K sh	$1.28	+$13.6K	31,076
2019-10-01	Aceragen, Inc.A Award	Director	AAward	+5,098 sh	$2.67	+$13.6K	20,443
2019-07-01	Aceragen, Inc.A Award	Director	AAward	+5,179 sh	$2.61	+$13.5K	15,345
2019-06-10	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2019-06-04	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11.5K sh	—	—	11,500
2019-05-15	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-04-01	Aceragen, Inc.A Award	Director	AAward	+5,166 sh	$2.59	+$13.4K	10,166
2018-12-19	Aceragen, Inc.P Purchase	Director	PPurchase	+5,000 sh	$3.33	+$16.7K	5,000
2018-12-18	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000

Recent filings

Accepted (ET)
Jun 124
SCHAFER CAROL0001272181-26-000006
SEC(opens sec.gov)
Jun 44
SCHAFER CAROL0001193125-26-257898
SEC(opens sec.gov)
May 154
SCHAFER CAROL0001272181-26-000004
SEC(opens sec.gov)
Jan 284
SCHAFER CAROL0001272181-26-000002
SEC(opens sec.gov)
Jun 124
SCHAFER CAROL0001415889-25-016990
SEC(opens sec.gov)
Jun 64
SCHAFER CAROL0000950170-25-083038
SEC(opens sec.gov)
May 194
SCHAFER CAROL0001628280-25-026568
SEC(opens sec.gov)
Jun 204
SCHAFER CAROL0001415889-24-017662
SEC(opens sec.gov)
Jun 184
SCHAFER CAROL0001415889-24-017524
SEC(opens sec.gov)
Jun 74
SCHAFER CAROL0000950170-24-070699
SEC(opens sec.gov)
May 154
SCHAFER CAROL0001628280-24-023569
SEC(opens sec.gov)
Jan 44
SCHAFER CAROL0001209191-24-000861
SEC(opens sec.gov)
Jun 124
SCHAFER CAROL0001209191-23-036336
SEC(opens sec.gov)
Jun 24
SCHAFER CAROL0001209191-23-033879
SEC(opens sec.gov)
May 154
SCHAFER CAROL0001628280-23-018209
SEC(opens sec.gov)
Jun 274
SCHAFER CAROL0001415889-22-006938
SEC(opens sec.gov)
Jun 234
SCHAFER CAROL0001209191-22-038936
SEC(opens sec.gov)
May 164
SCHAFER CAROL0001209191-22-029376
SEC(opens sec.gov)
May 134
SCHAFER CAROL0001140361-22-019178
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100

BOTHELL, WA, 98011